Business & Finance Consultingsp. z o.o.

Other activities auxiliary to insurance and pension funding

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2018-09-20
Share capital
10,000.00 PLN
Registered address
ul. Juliusza Słowackiego 8, 38-300 Gorlice, Poland

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 54 days early.

  • 202512/06/2026
  • 202430/06/2025
  • 202329/05/2024
  • 202231/03/2023
  • 202130/05/2022
  • 202029/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 56.38kMedianUSD 82.48kAverageUSD 1.66m
Net profit
This companyUSD 7.95kMedianUSD 3.29kAverageUSD 75.82k
Operating costs
This companyUSD 47.63kMedianUSD 57.85kAverageUSD 1.55m
Assets
This companyUSD 45.99kMedianUSD 57.17kAverageUSD 918.88k

Authorized Representatives

Paweł Mariusz Gucwa – President of the Management Board
Jakub Tarsa – Attorney-in-fact

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
Paweł Mariusz Gucwaage 42
85$2,296.0685%
Jakub Tarsaage 35
15$405.1915%

Beneficial owners

Person

Debt

No entries in the National Debtors Register (KRZ).

Public aid

7 public aid cases recorded, with a total value of $17,173.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$774
Other crisis aid
$3,616
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$721

Competitors

FAQ

Last updated: 2026-06-12